Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Comparisons of In Vivo and In Vitro Opioid Effects of Newly Synthesized 14-Methoxycodeine-6-O-sulfate and Codeine-6-O-sulfate.

Zádor F, Mohammadzadeh A, Balogh M, Zádori ZS, Király K, Barsi S, Galambos AR, László SB, Hutka B, Váradi A, Hosztafi S, Riba P, Benyhe S, Fürst S, Al-Khrasani M.

Molecules. 2020 Mar 17;25(6). pii: E1370. doi: 10.3390/molecules25061370.

2.

Synthesis, biochemical, pharmacological characterization and in silico profile modelling of highly potent opioid orvinol and thevinol derivatives.

Szűcs E, Marton J, Szabó Z, Hosztafi S, Kékesi G, Tuboly G, Bánki L, Horváth G, Szabó PT, Tömböly C, Varga ZK, Benyhe S, Ötvös F.

Eur J Med Chem. 2020 Apr 1;191:112145. doi: 10.1016/j.ejmech.2020.112145. Epub 2020 Feb 15.

PMID:
32092588
3.

Discovery of Kynurenines Containing Oligopeptides as Potent Opioid Receptor Agonists.

Szűcs E, Stefanucci A, Dimmito MP, Zádor F, Pieretti S, Zengin G, Vécsei L, Benyhe S, Nalli M, Mollica A.

Biomolecules. 2020 Feb 12;10(2). pii: E284. doi: 10.3390/biom10020284.

4.

Discovery of Novel µ-Opioid Receptor Inverse Agonist from a Combinatorial Library of Tetrapeptides through Structure-Based Virtual Screening.

Poli G, Dimmito MP, Mollica A, Zengin G, Benyhe S, Zador F, Stefanucci A.

Molecules. 2019 Oct 27;24(21). pii: E3872. doi: 10.3390/molecules24213872.

5.

Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions.

Zádor F, Nagy-Grócz G, Kekesi G, Dvorácskó S, Szűcs E, Tömböly C, Horvath G, Benyhe S, Vécsei L.

Molecules. 2019 Oct 15;24(20). pii: E3709. doi: 10.3390/molecules24203709. Review.

6.

Affinity of fentanyl and its derivatives for the σ1-receptor.

Lipiński PFJ, Szűcs E, Jarończyk M, Kosson P, Benyhe S, Misicka A, Dobrowolski JC, Sadlej J.

Medchemcomm. 2019 Jun 13;10(7):1187-1191. doi: 10.1039/c9md00222g. eCollection 2019 Jul 1.

PMID:
31391893
7.

Functional characterization of a novel opioid, PZM21, and its effects on the behavioural responses to morphine.

Kudla L, Bugno R, Skupio U, Wiktorowska L, Solecki W, Wojtas A, Golembiowska K, Zádor F, Benyhe S, Buda S, Makuch W, Przewlocka B, Bojarski AJ, Przewlocki R.

Br J Pharmacol. 2019 Dec;176(23):4434-4445. doi: 10.1111/bph.14805. Epub 2019 Dec 8.

PMID:
31347704
8.

Efficacy-Based Perspective to Overcome Reduced Opioid Analgesia of Advanced Painful Diabetic Neuropathy in Rats.

Balogh M, Zádor F, Zádori ZS, Shaqura M, Király K, Mohammadzadeh A, Varga B, Lázár B, Mousa SA, Hosztafi S, Riba P, Benyhe S, Gyires K, Schäfer M, Fürst S, Al-Khrasani M.

Front Pharmacol. 2019 Apr 9;10:347. doi: 10.3389/fphar.2019.00347. eCollection 2019.

9.

Biochemical and pharmacological investigation of novel nociceptin/OFQ analogues and N/OFQ-RYYRIK hybrid peptides.

Erdei AI, Borbély A, Magyar A, Szűcs E, Ötvös F, Gombos D, Al-Khrasani M, Stefanucci A, Dimmito MP, Luisi G, Mollica A, Benyhe S.

Peptides. 2019 Feb;112:106-113. doi: 10.1016/j.peptides.2018.11.010. Epub 2018 Dec 1.

PMID:
30513351
10.

Alterations in the Activity of Spinal and Thalamic Opioid Systems in a Mice Neuropathic Pain Model.

Rojewska E, Wawrzczak-Bargiela A, Szucs E, Benyhe S, Starnowska J, Mika J, Przewlocki R, Przewlocka B.

Neuroscience. 2018 Oct 15;390:293-302. doi: 10.1016/j.neuroscience.2018.08.013. Epub 2018 Sep 1.

PMID:
30176322
11.

Biochemical and pharmacological characterization of three opioid-nociceptin hybrid peptide ligands reveals substantially differing modes of their actions.

Erdei AI, Borbély A, Magyar A, Taricska N, Perczel A, Zsíros O, Garab G, Szűcs E, Ötvös F, Zádor F, Balogh M, Al-Khrasani M, Benyhe S.

Peptides. 2018 Jan;99:205-216. doi: 10.1016/j.peptides.2017.10.005. Epub 2017 Oct 13.

PMID:
29038035
12.

14-O-Methylmorphine: A Novel Selective Mu-Opioid Receptor Agonist with High Efficacy and Affinity.

Zádor F, Balogh M, Váradi A, Zádori ZS, Király K, Szűcs E, Varga B, Lázár B, Hosztafi S, Riba P, Benyhe S, Fürst S, Al-Khrasani M.

Eur J Pharmacol. 2017 Nov 5;814:264-273. doi: 10.1016/j.ejphar.2017.08.034. Epub 2017 Aug 30.

PMID:
28864212
13.

Cyclic Biphalin Analogues Incorporating a Xylene Bridge: Synthesis, Characterization, and Biological Profile.

Stefanucci A, Carotenuto A, Macedonio G, Novellino E, Pieretti S, Marzoli F, Szűcs E, Erdei AI, Zádor F, Benyhe S, Mollica A.

ACS Med Chem Lett. 2017 Jul 12;8(8):858-863. doi: 10.1021/acsmedchemlett.7b00210. eCollection 2017 Aug 10.

14.

Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine.

Nagy-Grócz G, Zádor F, Dvorácskó S, Bohár Z, Benyhe S, Tömböly C, Párdutz Á, Vécsei L.

Int J Mol Sci. 2017 Jul 30;18(8). pii: E1617. doi: 10.3390/ijms18081617. Review.

15.

New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology.

Zádor F, Király K, Váradi A, Balogh M, Fehér Á, Kocsis D, Erdei AI, Lackó E, Zádori ZS, Hosztafi S, Noszál B, Riba P, Benyhe S, Fürst S, Al-Khrasani M.

Eur J Pharmacol. 2017 Aug 15;809:111-121. doi: 10.1016/j.ejphar.2017.05.024. Epub 2017 May 11.

PMID:
28502630
16.

Opioid Receptor Activity and Analgesic Potency of DPDPE Peptide Analogues Containing a Xylene Bridge.

Stefanucci A, Novellino E, Mirzaie S, Macedonio G, Pieretti S, Minosi P, Szűcs E, Erdei AI, Zádor F, Benyhe S, Mollica A.

ACS Med Chem Lett. 2017 Mar 14;8(4):449-454. doi: 10.1021/acsmedchemlett.7b00044. eCollection 2017 Apr 13.

17.

Kynurenic acid and its analogue can alter the opioid receptor G-protein signaling after acute treatment via NMDA receptor in rat cortex and striatum.

Samavati R, Zádor F, Szűcs E, Tuka B, Martos D, Veres G, Gáspár R, Mándity IM, Fülöp F, Vécsei L, Benyhe S, Borsodi A.

J Neurol Sci. 2017 May 15;376:63-70. doi: 10.1016/j.jns.2017.02.053. Epub 2017 Feb 27.

PMID:
28431630
18.

Characterization of [3H] oxymorphone binding sites in mouse brain: Quantitative autoradiography in opioid receptor knockout mice.

Yoo JH, Borsodi A, Tóth G, Benyhe S, Gaspar R, Matifas A, Kieffer BL, Metaxas A, Kitchen I, Bailey A.

Neurosci Lett. 2017 Mar 16;643:16-21. doi: 10.1016/j.neulet.2017.02.002. Epub 2017 Feb 10.

PMID:
28192197
19.

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors.

Mollica A, Pelliccia S, Famiglini V, Stefanucci A, Macedonio G, Chiavaroli A, Orlando G, Brunetti L, Ferrante C, Pieretti S, Novellino E, Benyhe S, Zador F, Erdei A, Szucs E, Samavati R, Dvrorasko S, Tomboly C, Ragno R, Patsilinakos A, Silvestri R.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):444-451. doi: 10.1080/14756366.2016.1260565.

20.

Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia.

Szűcs E, Dvorácskó S, Tömböly C, Büki A, Kékesi G, Horváth G, Benyhe S.

Neurosci Lett. 2016 Oct 28;633:87-93. doi: 10.1016/j.neulet.2016.09.020. Epub 2016 Sep 14.

PMID:
27639959

Supplemental Content

Loading ...
Support Center